We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Leveraging biotech's drug discovery expertise for neglected diseases.
- Authors
Lowell, Joanna E; Earl, Christopher D
- Abstract
This opinion piece states that, while strategies to develop medicines for neglected infectious diseases have largely focused on resources from the public sector and large pharmaceutical companies, drug discovery programs should focus more extensively on mid-tier biotechnology companies. With billions of dollars in equity and numerous approved products, the biotechnology industry could be used to produce drugs, diagnostics, and vaccines for illnesses such as malaria and tuberculosis.
- Subjects
DRUG development; BIOTECHNOLOGY industry research; VACCINE research; MALARIA treatment; TUBERCULOSIS treatment
- Publication
Nature Biotechnology, 2009, Vol 27, Issue 4, p323
- ISSN
1087-0156
- Publication type
Opinion
- DOI
10.1038/nbt0409-323